|
Gliomas RTOG 0424
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen
for High Risk Low-Grade Gliomas
Glioblastoma RTOG 0525
A Phase III Trial Comparing Conventional Adjuvant Temozolomide
With Dose-Intensive Temozolomide in Patients with Newly Diagnosed
Glioblastoma
[top]
Breast CTLM
Computed Tomography Laser Mammography (CTLM ®) System Model
1020
Breast RTOG 0413/NSABP B-39
A Randomized Phase III Study of Conventional Whole Breast Irradiation
(WBI) vs. Partial Breast Irradiation (PBI) for Women with Stage
0, I or II Breast Cancer (some limitations as of 12/12/06)
Breast ECOG (TAILORx
Trial)
A Phase III Randomized Study of Adjuvant Combination Chemotherapy
and Hormonal Therapy vs. Adjuvant Hormonal Therapy Alone in Women
with Previously Resected Axillary Node-Negative Breast Cancer with
Various Levels of Risk for Recurrence
Breast
IBCSG 24-02 (Suppression of Ovarian Function Trial/SOFT)
A Phase III Trial Evaluating the Role of Ovarian Function Suppression
and the Role of Exemestane Adjuvant Therapies for Premenopausal
Women with Endocrine Responsive Breast Cancer
Breast ABI/CA023 ABI
A Randomized Phase II Trial of Weekly vs. Every Two-Week vs. Every
Three-Week Administration of ABI-007 in Combination with Bevacizumab
in Women with Metastatic Breast Cancer
Breast SWOG SO226
A Phase III Randomized Trial of Anastrozole vs. Anastrozole and
Fulvestrant as First Line Therapy for Post Menopausal Women with
Metastatic Breast Cancer
[top]
Rectal ECOG
E5204
A Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil
and Leucovorin vs. Oxaliplatin, 5-Fluorouracil, Leucovorin and
Bevacizumab for Stage II or III Rectal Cancer Receiving Pre-Operative
Chemoradiation
RTOG 0529
A Phase II Evaluation of Dose-Painted IMRT in Combination with
5-Flurouracil and Mitomycin–C for Reduction of Acute Morbidity
in Carcinoma of the Anal Canal
Liver RTOG 0438
A Phase I Trial of Highly Conformal Radiation Therapy for Patients
with Liver Metastases
9/12/07 Temporarily Closed
[top]
Prostate MMC
Phase I/II Study to Evaluate Feasibility and Validation
of Intensity Modulated Radiation Therapy (IMRT) for Prostate Cancer
at High Dose Levels
Prostate
CALGB 90401
A Phase III Trial Comparing Docetaxel and Prednisone with/without
Bevacizumab in Men with Hormone Refractory Prostate Cancer
Renal Cell ECOG E2805
A Randomized Double-Blind Phase III Trial of Adjuvant Sunitinib
vs. Sorafenib vs. Placebo in Patients with Resected Renal Cell Carcinoma
[top]
Ovarian GOG
0218
A Phase III Trial of Carboplatin and Paclitaxel plus Placebo vs.
Carboplatin and Paclitaxel, plus Concurrent Bevacizumab (NSC #744865,
IND #7921), Followed by Placebo vs. Carboplatin and Paclitaxel,
plus Concurrent and Extended Bevacizumab, in Women with Newly Diagnosed,
Previously Untreated, Stage III (Suboptimal) and All Stage IV,
Epithelial Ovarian or Primary Peritoneal Cancer
RTOG 0418
A Phase II Study of Intensity Modulated Radiation Therapy (IMRT)
to the Pelvis +/- Chemotherapy for Post-Operative Patients with
either Endometrial or Cervical Carcinoma
[top]
RTOG 0435
A Randomized Phase III, Double –Blind, Placebo Controlled
Study to Evaluate the Efficacy and Safety of Palifermin for the Reduction
of Oral Mucositis in Patients with Locally Advanced Head and Neck
Cancer Receiving Radiation Therapy with Concurrent Chemotherapy.
(Followed by surgery for selected patients)
RTOG 0514
Establishment of a Head and Neck Tissue Bank
[top]
GSK 109493
A Double-Blind, Randomized, Placebo-Controlled Phase III Study
to Assess the Efficacy of recMAGE-A3 + AS15 Antigen-Specific
Cancer Immunotherapeutic as Adjuvant Therapy in Patients with
Resectable MAGE-A3(+) positive Non-Small Cell Lung Cancer
RTOG 0127/E5597
Phase III Chemoprevention Trial of Selenium Supplementation
in Persons with Resected Stage I Non-Small Cell Lung Cancer
Small Cell Lung Cancer RTOG 0212
A Phase I/II Randomized Trial of Two Doses (Phase III-Standard
vs. High) and Two Dose High Schedule (Phase II-Once vs. Twice
Daily) for Delivering Prophylactic Cranial Irradiation for Patients
with Limited Disease Small Cell Lung Cancer
Non-Small Cell Lung Cancer ACOSOG
Z4032
A Randomized Phase III Study of Sublobar Resection vs. Sublobar
Resection, plus Brachytherapy in High-Risk Patients with Non-Small
Cell Lung Cancer 3 cm or Smaller
RTOG 0617
A Randomized Phase III Comparison of Standard- Dose (60 Gy) Versus
High-Dose (74 Gy) Conformal Radiotherapy with Concurrent and
Consolidation Carboplatin/Paclitaxel in Patients with Stage IIIA/IIIB
Non-Small Cell Lung Cancer
[top]
MMC
Study of Stereotactic Body Radiotherapy for Recurrent or Metastatic
Lesions to the Lung, Liver, Spine and Viscera
AVF3991N/Registry
An Observational Study of Avastin (Bevacizumab) in Combination
with Chemotherapy for Treatment of Metastatic or Locally Advanced
and Unresectable Colorectal Cancer, Metastatic or Locally Advanced
Non-Small Cell Lung Cancer (excluding Predominant Squamous Cell Histology),
Metastatic or Locally Recurrent Breast Cancer
Caphosol® Oral Mucositis Follow-Up Observational Registry
Trial
COMFORT
An Open-Label, Multicenter, Uncontrolled Observational Registry
in Patients who are Expected to Receive Radiation and/or Chemotherapy
that places the Patient at Risk for Developing Oral Mucositis.
MMC
Phase III Randomized Study of Calendula vs. Biafine to Prevent
Radiation-Induced Dermatitis
[ top ] |
